These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 2086823

  • 1. [Clinical evaluation of imipenem/cilastatin sodium against severe infections in patients with hematopoietic disorders].
    Tsukada T, Katayama N, Kageyama S, Nishikawa M, Kobayashi T, Deguchi K, Shirakawa S, Minami N.
    Jpn J Antibiot; 1990 Dec; 43(12):2087-93. PubMed ID: 2086823
    [Abstract] [Full Text] [Related]

  • 2. [Therapeutic effects of imipenem/cilastatin sodium against severe infections in patients with hematopoietic disorders. Hanshin Infection Study Group].
    Tatsumi N, Nin T, Sannomiya Y, Kageyama T, Ohyabu H, Akasaka K, Nasu K, Yonezawa T, Tominaga N, Kitani T.
    Jpn J Antibiot; 1989 May; 42(5):1065-76. PubMed ID: 2664253
    [Abstract] [Full Text] [Related]

  • 3. [Clinical evaluation of imipenem/cilastatin sodium in infectious complications of hematological malignancies. Tohkai Research Group on Infections in Hematological Disorders].
    Naito K, Kobayashi M, Okumura M, Ikeda Y, Mitomo Y, Oguri T, Tanaka M, Ohara K, Kodera Y, Ohno R.
    Jpn J Antibiot; 1990 Aug; 43(8):1371-80. PubMed ID: 2283705
    [Abstract] [Full Text] [Related]

  • 4. [Comparison between monotherapy with imipenem/cilastatin sodium (IPM/CS) and combinations of IPM/CS and other drugs for treating bacterial infections in patients with hematopoietic disorders].
    Sawae Y, Niho Y, Okamura T, Gondo H, Kozuru M, Uike N, Muta K, Goto T, Suehiro Y, Kumakawa M, Nishimura J, Yufu Y, Ishikura H, Yamashita S, Hisano S, Morioka E, Nakajima H, Shibuya T, Yamasaki K, Harada N, Asayama R, Hayashi S, Akashi K, Suematsu E, Kawasaki C.
    Jpn J Antibiot; 1996 Dec; 49(12):1049-61. PubMed ID: 9032592
    [Abstract] [Full Text] [Related]

  • 5. [Therapeutic evaluation of imipenem/cilastatin sodium for bacterial infections in patients with hematological diseases].
    Sawae Y, Niho Y, Harada M, Shibuya T, Okamura T, Asano Y, Taniguchi S, Murakawa M, Toyoshima T, Kozuru M.
    Jpn J Antibiot; 1992 Feb; 45(2):123-35. PubMed ID: 1613965
    [Abstract] [Full Text] [Related]

  • 6. [Clinical evaluation of imipenem/cilastatin sodium as a second line regimen in severe infections associated with hematologic disorders].
    Tsuda S, Nakai H, Murakami T, Seryu S, Takashima T, Tanaka S, Nakagawa H, Nishigaki H, Okuda T, Nishida K.
    Jpn J Antibiot; 1991 Aug; 44(8):886-98. PubMed ID: 1920814
    [Abstract] [Full Text] [Related]

  • 7. [Chemotherapy with imipenem/cilastatin for severe infections accompanied by malignant hematological disorders].
    Fujii Y, Inoue Y, Hiroshige Y, Kaku K, Kaneko T.
    Jpn J Antibiot; 1993 Mar; 46(3):259-68. PubMed ID: 8510323
    [Abstract] [Full Text] [Related]

  • 8. [Laboratory and clinical studies on imipenem/cilastatin sodium plus amikacin sulfate in patients with severe infections complicating hematological disorders].
    Hotta T, Morishima Y, Saito H, Kodera Y, Hirabayashi N, Tanaka M, Mizuno H, Suzuki H, Kato Y, Morishita Y.
    Jpn J Antibiot; 1991 May; 44(5):515-28. PubMed ID: 1880931
    [Abstract] [Full Text] [Related]

  • 9. [Pharmacokinetic and clinical evaluation of imipenem/cilastatin sodium in neonates and premature infants. A study of imipenem/cilastatin sodium by a perinatal co-research group].
    Fujii R, Sakata H, Inyaku F, Fujita K, Maruyama S, Yoshioka H, Hashira S, Tajima T, Nakazawa S, Sato H.
    Jpn J Antibiot; 1989 Apr; 42(4):953-72. PubMed ID: 2671429
    [Abstract] [Full Text] [Related]

  • 10. [Effect of a combination treatment using imipenem/cilastatin sodium with G-CSF on infections in neutropenic patients with hematological malignancies].
    Sawada H, Sasada M, Tajima M, Yamamoto K, Yasuda N, Omori S, Yumoto Y, Ishibashi T, Okada H, Suzuki T.
    Jpn J Antibiot; 1995 Feb; 48(2):271-7. PubMed ID: 7538179
    [Abstract] [Full Text] [Related]

  • 11. [A comparative study of imipenem/cilastatin sodium BID vs QID in the treatment of infections associated with hematopoietic disorders].
    Sawae Y, Niho Y, Okamura T, Murakawa M, Teshima T, Fujisaki T, Ikeda K, Kozuru M, Uike N, Katsuno M.
    Jpn J Antibiot; 1994 Oct; 47(10):1318-28. PubMed ID: 7807693
    [Abstract] [Full Text] [Related]

  • 12. [Pharmacokinetic, bacteriological and clinical studies on imipenem/cilastatin sodium in neonates].
    Iwai N, Nakamura H, Miyazu M, Kasai K, Taneda Y.
    Jpn J Antibiot; 1989 May; 42(5):1087-101. PubMed ID: 2746858
    [Abstract] [Full Text] [Related]

  • 13. [Clinical evaluation of imipenem/cilastatin sodium and fosfomycin as second-line combination chemotherapy in severe infections associated with hematologic disorders].
    Tsuda S, Kuzuyama Y, Nakai H, Seriu T, Takashima T, Tanaka S, Horiike S, Taniwaki M, Misawa S, Kashima K.
    Jpn J Antibiot; 1993 Feb; 46(2):171-83. PubMed ID: 8331778
    [Abstract] [Full Text] [Related]

  • 14. [Clinical evaluation of imipenem/cilastatin sodium against severe infections complicated with hematological disorders and solid tumors].
    Takemori H, Sakata Y, Ogasawara H, Haga Y, Sawada Y, Aihara M, Sasaki D, Yoshida Y, Chiba Y, Suzuki A.
    Jpn J Antibiot; 1989 Dec; 42(12):2566-73. PubMed ID: 2614913
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Clinical studies on imipenem/cilastatin sodium in the perinatal period].
    Matsuda S, Suzuki M, Oh K.
    Jpn J Antibiot; 1988 Nov; 41(11):1774-7. PubMed ID: 3210307
    [Abstract] [Full Text] [Related]

  • 17. [Clinical evaluation of imipenem/cilastatin sodium in the internal medicine].
    Fukuhara H, Kusano N, Nakamura H, Kaneshima H, Irabu Y, Shimozi K, Kitukawa K, Shigeno Y, Saito A, Kakazu T.
    Jpn J Antibiot; 1991 Aug; 44(8):877-85. PubMed ID: 1920813
    [Abstract] [Full Text] [Related]

  • 18. [Clinical studies on imipenem/cilastatin sodium in perinatal use].
    Chimura T, Morisaki N, Hirayama T, Matsuo M.
    Jpn J Antibiot; 1988 Nov; 41(11):1751-7. PubMed ID: 3210306
    [Abstract] [Full Text] [Related]

  • 19. [Clinical studies on imipenem/cilastatin sodium in the field of obstetrics and gynecology in the perinatal period].
    Tateno M.
    Jpn J Antibiot; 1988 Nov; 41(11):1786-91. PubMed ID: 3210309
    [Abstract] [Full Text] [Related]

  • 20. [Evaluation of imipenem/cilastatin sodium in neonatal infections].
    Okura KE, Haruta T, Kanamoto T, Kobayashi Y.
    Jpn J Antibiot; 1988 Nov; 41(11):1715-20. PubMed ID: 3210303
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.